21 CFR Part 11: Where Are We Now?

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-01-2003
Volume 2003 Supplement
Issue 5

FDA's revised guidance on 21 CFR Part 11 offers relief to the regulated industry by providing for enforcement discretion and suggesting a risk-based approach to compliance.

Recent Videos
Behind the Headlines, Episode 10
Jens Schmidt, associate director MSAT at Lonza